US 10233142
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted A61KA61K31/133A61K31/165
Quick answer
US patent 10233142 (Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide) held by VANDA PHARMACEUTICALS INC. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/133, A61K31/165, A61P, A61P15/00